These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7546279)

  • 1. Role of mast cells in atherosclerosis.
    Kovanen PT
    Chem Immunol; 1995; 62():132-70. PubMed ID: 7546279
    [No Abstract]   [Full Text] [Related]  

  • 2. The mast cell--a potential link between inflammation and cellular cholesterol deposition in atherogenesis.
    Kovanen PT
    Eur Heart J; 1993 Dec; 14 Suppl K():105-17. PubMed ID: 8131778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cell granule-mediated uptake of low density lipoproteins by macrophages: a novel carrier mechanism leading to the formation of foam cells.
    Kovanen PT
    Ann Med; 1991; 23(5):551-9. PubMed ID: 1756025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble heparin proteoglycans released from stimulated mast cells induce uptake of low density lipoproteins by macrophages via scavenger receptor-mediated phagocytosis.
    Lindstedt KA; Kokkonen JO; Kovanen PT
    J Lipid Res; 1992 Jan; 33(1):65-75. PubMed ID: 1552234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in cholesterol transport by lipoproteins in patients with renal insufficiency].
    Pérez A; Alegre B; Panadero J; Martín L; Breto M; Cruz JM
    Rev Clin Esp; 1983 Jan; 168(1):13-6. PubMed ID: 6844674
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid.
    Lindstedt L; Lee M; Kovanen PT
    Atherosclerosis; 2001 Mar; 155(1):87-97. PubMed ID: 11223430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoke and lipoprotein modification. A possible interpretation for development of atherosclerosis.
    Yokode M; Nagano Y; Arai H; Ueyama K; Ueda Y; Kita T
    Ann N Y Acad Sci; 1995 Jan; 748():294-300. PubMed ID: 7695173
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of mast cells in atherosclerosis.
    Metzler B; Xu Q
    Int Arch Allergy Immunol; 1997 Sep; 114(1):10-4. PubMed ID: 9303325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential abilities of mouse liver parenchymal and nonparenchymal cells in HDL and LDL (native and oxidized) association and cholesterol efflux.
    Lapointe J; Truong TQ; Falstrault L; Brissette L
    Biochem Cell Biol; 2006 Apr; 84(2):250-6. PubMed ID: 16609706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oxidative stress and atherosclerotic diseases].
    Yokode M
    Nihon Ronen Igakkai Zasshi; 1997 Sep; 34(9):711-5. PubMed ID: 9430980
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma lipoproteins and atherosclerosis.
    Tikkanen MJ
    J Diabet Complications; 1990; 4(2):35-8. PubMed ID: 2145293
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxidative modification of low density lipoprotein and its relation to atherosclerosis.
    Aviram M
    Isr J Med Sci; 1995 Apr; 31(4):241-9. PubMed ID: 7721566
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metabolism of atherogenic lipoproteins].
    Beucler I; Turpin G
    Ann Med Interne (Paris); 2001 Apr; 152(3):158-61. PubMed ID: 11431574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell-mediated inhibition of reverse cholesterol transport.
    Lee M; Lindstedt LK; Kovanen PT
    Arterioscler Thromb; 1992 Nov; 12(11):1329-35. PubMed ID: 1420092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenesis and the role of lipoproteins.
    Stender S
    Scand J Clin Lab Invest Suppl; 1990; 199():14-6. PubMed ID: 2191412
    [No Abstract]   [Full Text] [Related]  

  • 17. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol.
    Tabas I
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S12-6. PubMed ID: 15143347
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cholesterol transport by low-density lipoproteins and the problem of arteriosclerosis].
    Lutz W; Jazdzewski B
    Pol Tyg Lek; 1980 Jan; 35(4):141-4. PubMed ID: 6988821
    [No Abstract]   [Full Text] [Related]  

  • 20. Contribution of HDL-apolipoproteins to the inhibition of low density lipoprotein oxidation and lipid accumulation in macrophages.
    Lin KY; Chen YL; Shih CC; Pan JP; Chan WE; Chiang AN
    J Cell Biochem; 2002; 86(2):258-67. PubMed ID: 12111995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.